Theraclion specialises in high-tech medical equipment using high-intensity focused ultrasound (HIFU). We offer an innovative echotherapy solution that combines HIFU therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumours and varicose veins.
Theraclion a French company created in 2004, a pioneer in the use of ultrasound for therapeutic purposes. Theraclion develops, manufactures and markets medical devices, the Echopulse®, for non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules. And the SONOVEIN® for the treatment of varicose veins of the lower limps.
Theraclion is ISO 13 485 certified and has received the CE mark for these 3 pathologies.
Located in Malakoff, near Paris, Theraclion has a team of 24 people, 53% of whom are dedicated to R & D and clinical trials.
Theraclion is now the only company in the world to offer a completely non-invasive treatment for breast adenofibromas, benign thyroid nodules and varicose veins and is the only company specializing in superficial targets. This solution presents today an alternative to surgery and minimally invasive techniques.
Theraclion is listed on Alternext Paris Eligible for PEA-PME Mnemonic ALTHE – ISIN code: FR0010120402.